4
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-24-000708
Director bought 33,333 shares at $0.30 ($10,000)
From the SEC's structured data for this filing
Trades in this filing
Gumulka Jerzy · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-01 | Purchase : show line 1 in the form | +33,333 | $0.30 | $10,000 | 43,006 | D |
| Open-market purchases · 33,333 sh · avg $0.30 · $10,000 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-01 | Grant or award : show line 2 in the form Series A Warrant to purchase common stock | +33,333 | 78,761 | D |
| 2024-02-01 | Grant or award : show line 3 in the form Series B Warrant to purchase common stock | +33,333 | 112,094 | D |
Loading xslF345X05/ownership.xml…